DURECT (DRRX) News Today $1.91 0.00 (0.00%) As of 09/11/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DRRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Traders Buy Large Volume of DURECT Put Options (NASDAQ:DRRX)September 12, 2025 | marketbeat.comDurect Merges with Bausch Health, Delists from NasdaqSeptember 11, 2025 | tipranks.comDURECT Sees Unusually High Options Volume (NASDAQ:DRRX)September 11, 2025 | americanbankingnews.comDURECT (NASDAQ:DRRX) Shares Pass Above Two Hundred Day Moving Average - Time to Sell?September 7, 2025 | marketbeat.comDURECT (NASDAQ:DRRX) Stock Price Crosses Above 200 Day Moving Average - What's Next?August 29, 2025 | marketbeat.comBausch Health announces extension of Durect tender offerAugust 26, 2025 | msn.comDURECT Corporation Stock (DRRX) Opinions on Potential Acquisition by Bausch HealthAugust 22, 2025 | quiverquant.comQDURECT Corporation (NASDAQ:DRRX) Sees Significant Drop in Short InterestAugust 20, 2025 | marketbeat.comDURECT (NASDAQ:DRRX) Stock Price Passes Above 200 Day Moving Average - Here's What HappenedAugust 20, 2025 | marketbeat.comDURECT (NASDAQ:DRRX) Releases Earnings Results, Beats Expectations By $0.06 EPSAugust 14, 2025 | marketbeat.comDurect, Bausch Health merger expected to close in Q3August 12, 2025 | msn.comDurect options imply 6.9% move in share price post-earningsAugust 12, 2025 | msn.comDURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on ...August 12, 2025 | gurufocus.comDURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch HealthAugust 12, 2025 | prnewswire.comDalton Investments Inc. Has $411,000 Holdings in DURECT Corporation (NASDAQ:DRRX)August 12, 2025 | marketbeat.comDURECT (NASDAQ:DRRX) Stock Passes Above 200-Day Moving Average - Time to Sell?August 10, 2025 | marketbeat.comBausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease TreatmentAugust 9, 2025 | insidermonkey.comBausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease TreatmentAugust 8, 2025 | msn.comDurect Extends Tender Offer Deadline in MergerAugust 8, 2025 | tipranks.comDURECT (DRRX) Projected to Post Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comDURECT (NASDAQ:DRRX) Stock Price Passes Above Two Hundred Day Moving Average - Should You Sell?August 2, 2025 | marketbeat.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of DURECT Corporation (NASDAQ: DRRX)July 31, 2025 | globenewswire.comBausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT BuyoutJuly 29, 2025 | benzinga.comDRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to ShareholdersJuly 29, 2025 | tmcnet.comShareholder Alert: The Ademi Firm Investigates Whether DURECT Corporation Is Obtaining a Fair Price for Its Public ShareholdersJuly 29, 2025 | tmcnet.comBausch Health stock rises, Durect flies after acquisition dealJuly 29, 2025 | za.investing.comDurect Merges with Bausch Health for $1.75/ShareJuly 29, 2025 | tipranks.comBausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver DiseaseJuly 29, 2025 | prnewswire.comDURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 13, 2025 | prnewswire.comOppenheimer Sticks to Its Buy Rating for Durect (DRRX)March 30, 2025 | markets.businessinsider.comHere's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn SituationMarch 28, 2025 | finance.yahoo.comDURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call TranscriptMarch 28, 2025 | msn.comDURECT outlines $20M Phase 3 trial for larsucosterol in alcohol-associated hepatitisMarch 27, 2025 | msn.comDURECT Corporation (DRRX) Q4 2024 Earnings Call TranscriptMarch 26, 2025 | seekingalpha.comDURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 26, 2025 | prnewswire.comDURECT Q4 2024 Earnings PreviewMarch 25, 2025 | msn.comDURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business UpdateMarch 19, 2025 | prnewswire.comDurect Corporation Announces Board Member’s RetirementFebruary 21, 2025 | tipranks.comDURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | prnewswire.comH.C. Wainwright views Durect as significant ‘going concern’ riskJanuary 30, 2025 | markets.businessinsider.comDURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM EvidenceJanuary 28, 2025 | prnewswire.comOppenheimer Remains a Buy on Durect (DRRX)November 27, 2024 | markets.businessinsider.comDurect announces sale of Alzet line of osmotic pumps to LIC for $17.5MNovember 26, 2024 | markets.businessinsider.comDurect (DRRX) Gets a Buy from Northland SecuritiesNovember 26, 2024 | markets.businessinsider.comDURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 MillionNovember 25, 2024 | prnewswire.comDURECT Corporation (NASDAQ:DRRX) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | msn.comDURECT Corporation (DRRX) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comDURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 13, 2024 | prnewswire.comAn Overview of Durect's EarningsNovember 13, 2024 | benzinga.comDURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business UpdateNovember 6, 2024 | prnewswire.com Get DURECT News Delivered to You Automatically Sign up to receive the latest news and ratings for DRRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DRRX Media Mentions By Week DRRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRRX News Sentiment▼0.700.92▲Average Medical News Sentiment DRRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRRX Articles This Week▼71▲DRRX Articles Average Week Get the Latest News and Ratings for DRRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for DURECT and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies VYGR News Today LYEL News Today TKNO News Today TNXP News Today SGMT News Today ACIU News Today ACRS News Today HUMA News Today AVTE News Today OGI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRRX) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DURECT Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share DURECT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
